Eloxx Pharmaceuticals Statistics

Total Valuation

Eloxx Pharmaceuticals has a market cap or net worth of 3. The enterprise value is 13.95 million.

Market Cap	3
Enterprise Value	13.95M

Important Dates

The next estimated earnings date is Monday, March 31, 2025.

Earnings Date	Mar 31, 2025
Ex-Dividend Date	n/a

Share Statistics

Eloxx Pharmaceuticals has 3.30 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	3.30M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+24.20%
Owned by Insiders (%)	6.42%
Owned by Institutions (%)	7.56%
Float	2.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.68
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.24

Current Ratio	0.24
Quick Ratio	0.20
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-12.60

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-73.24%
Return on Capital (ROIC)	-124.75%
Revenue Per Employee	n/a
Profits Per Employee	-1.14M
Employee Count	18
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -99.99% in the last 52 weeks. The beta is 2.56, so Eloxx Pharmaceuticals's price volatility has been higher than the market average.

Beta (5Y)	2.56
52-Week Price Change	-99.99%
50-Day Moving Average	0.00
200-Day Moving Average	0.44
Relative Strength Index (RSI)	13.68
Average Volume (20 Days)	770

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.28

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-19.29M
Pretax Income	-20.48M
Net Income	-20.48M
EBITDA	-19.24M
EBIT	-19.29M
Earnings Per Share (EPS)	-8.82

Full Income Statement

Balance Sheet

The company has 4.78 million in cash and 18.72 million in debt, giving a net cash position of -13.95 million or -4.23 per share.

Cash & Cash Equivalents	4.78M
Total Debt	18.72M
Net Cash	-13.95M
Net Cash Per Share	-4.23
Equity (Book Value)	-20.05M
Book Value Per Share	-6.53
Working Capital	-17.84M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-17.99M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Eloxx Pharmaceuticals does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.34%
Shareholder Yield	-7.34%
Earnings Yield	-881,628,000.00%
FCF Yield	n/a

Stock Splits

The last stock split was on December 2, 2022. It was a reverse split with a ratio of 0.025.

Last Split Date	Dec 2, 2022
Split Type	Reverse
Split Ratio	0.025

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a